you are here:

Ajanta Pharma Ltd.

BSE: 532331 | NSE: AJANTPHARM |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE031B01049 | SECTOR: Pharmaceuticals

BSE Live

Jun 18, 13:34
1923.95 -45.80 (-2.33%)
Volume
AVERAGE VOLUME
5-Day
6,062
10-Day
6,236
30-Day
6,251
4,802
  • Prev. Close

    1969.75

  • Open Price

    1963.90

  • Bid Price (Qty.)

    1920.75 (1)

  • Offer Price (Qty.)

    1922.50 (2)

NSE Live

Jun 18, 13:34
1921.75 -42.15 (-2.15%)
Volume
AVERAGE VOLUME
5-Day
97,037
10-Day
92,323
30-Day
122,989
38,334
  • Prev. Close

    1963.90

  • Open Price

    1970.00

  • Bid Price (Qty.)

    1920.75 (4)

  • Offer Price (Qty.)

    1921.75 (1)

ANNOUNCEMENTS ON Ajanta Pharma

  • Apr 22, 2021 12:35 Source: BSE

    Ajanta Pharma - Announcement under Regulation 30 (LODR)-Newspaper Publication

    Pursuant to Regulation 47 of the Listing Regulations, please find enclosed intimation about the meeting of Board of Directors of the Company to be held on Friday, 30th April 2021 published in the following newspapers on 22nd April 2021: 1. Mumbai edition of The Free Press Journal and 2. Mumbai edition of Navshakti; This is for your information and record.

  • Apr 21, 2021 14:29 Source: BSE

    Ajanta Pharma - Board Meeting Intimation for Considering And Approving Results

    AJANTA PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/04/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Listing Regulations, we hereby inform that a Meeting of the Board of Directors of the Company will be held on Friday, 30th April 2021 to inter-alia consider and approve: a. Audited Financial Results (consolidated & standalone) of the Company for the quarter and year ended 31st March 2021; and b. Audited Financial Statements (consolidated & standalone) for the year ended 31st March 2021. You are requested to please take note of the same and disseminate to all concerned.

  • Apr 20, 2021 14:19 Source: BSE

    Ajanta Pharma - Compliance With Reg.40(10) Of The Listing Regulations - Compliance Certificate

    Pursuant to Regulation 40(10) of the SEBI (Listing obligations and Disclosure Requirements) Regulations, 201 5, please find enclosed herewith a certificate from a Practicing Company Secretary for the half-year ended on 31st March 2021, the contents of which are self-explanatory. You are requested to kindly take the same on records and acknowledge receipt.

CORPORATE ANNOUNCEMENTS

BOARD MEETING

Meeting Date : Apr 30, 2021
Remark : Audited Results